This study demonstrates a comprehensive computational approach to identify and analyze potential small-molecule inhibitors targeting PCSK9, a critical regulator of LDL-c levels implicated in atherosclerosis and cardiovascular diseases. Here, PCSK9 is linked to atherosclerosis.